AR021663A1 - Clatratos de dehidroepiandrosterona y composiciones farmaceuticas correspondientes - Google Patents
Clatratos de dehidroepiandrosterona y composiciones farmaceuticas correspondientesInfo
- Publication number
- AR021663A1 AR021663A1 ARP990106362A ARP990106362A AR021663A1 AR 021663 A1 AR021663 A1 AR 021663A1 AR P990106362 A ARP990106362 A AR P990106362A AR P990106362 A ARP990106362 A AR P990106362A AR 021663 A1 AR021663 A1 AR 021663A1
- Authority
- AR
- Argentina
- Prior art keywords
- dehydroepiandrosterone
- clarrates
- corresponding pharmaceutical
- pharmaceutical compositions
- insufficiencies
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Nanotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Biotechnology (AREA)
- Pregnancy & Childbirth (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Gynecology & Obstetrics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invencion se refiere a clatratos de dehidroepiandrosterona, posiblemente en la forma de sulfatos, en una matriz que consiste de unaciclodextrina y opcionalmente comprende un agente de co-solubilizacion, y la correspondiente composicion farmacéutica adecuada para terapias de sustitucionpara el tratamiento de insuficiencias adrenocorticales.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1998MI002745A IT1304190B1 (it) | 1998-12-18 | 1998-12-18 | Clatrati di deidroepiandrosterone e relative composizionifarmaceutiche |
Publications (1)
Publication Number | Publication Date |
---|---|
AR021663A1 true AR021663A1 (es) | 2002-07-31 |
Family
ID=11381280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990106362A AR021663A1 (es) | 1998-12-18 | 1999-12-14 | Clatratos de dehidroepiandrosterona y composiciones farmaceuticas correspondientes |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1140110B1 (es) |
JP (1) | JP2002532565A (es) |
KR (1) | KR100693514B1 (es) |
CN (1) | CN1198620C (es) |
AR (1) | AR021663A1 (es) |
AT (1) | ATE243517T1 (es) |
AU (1) | AU759979B2 (es) |
BR (1) | BR9916288A (es) |
CA (1) | CA2355148A1 (es) |
CO (1) | CO5231137A1 (es) |
DE (1) | DE69909128T2 (es) |
DK (1) | DK1140110T3 (es) |
EA (1) | EA003304B1 (es) |
ES (1) | ES2203232T3 (es) |
HU (1) | HU225414B1 (es) |
IL (2) | IL143776A0 (es) |
IT (1) | IT1304190B1 (es) |
NZ (1) | NZ512795A (es) |
PE (1) | PE20001379A1 (es) |
PT (1) | PT1140110E (es) |
TR (1) | TR200101766T2 (es) |
TW (1) | TWI225791B (es) |
WO (1) | WO2000037109A2 (es) |
ZA (1) | ZA200105223B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2815860B1 (fr) * | 2000-10-26 | 2003-12-12 | Oreal | Composition, notamment cosmetique, comprenant la dhea et/ou precurseur ou derive de celle-ci et au moins un agent myorelaxant |
EP1285927A3 (de) * | 2001-08-16 | 2005-06-29 | Schering Aktiengesellschaft | Verwendung von Glucocorticoid-Rezeptorantagonisten zur Vorbeugung und Behandlung von Erkrankungen des männlichen Reproduktionssystems |
ITMI20021074A1 (it) * | 2002-05-20 | 2003-11-20 | Actimex S R L | Composizione ternaria comprendente una sostanza attiva e processo di comacinazione per la sua preparazione |
ITMI20022549A1 (it) * | 2002-12-02 | 2004-06-03 | Actimex S R L | Composizione quaternaria comprendente come sostanza attiva la propolis. |
CN1950110B (zh) * | 2004-04-01 | 2012-11-21 | 列日大学 | 嘧啶-2,4,6-三酮的药物组合物 |
JPWO2006137433A1 (ja) * | 2005-06-21 | 2009-01-22 | わかもと製薬株式会社 | レボカバスチンを可溶化させた水性薬剤 |
ITPD20050224A1 (it) * | 2005-07-19 | 2007-01-20 | Actimex Srl | Composizioni contenenti micronutrienti aventi in particolare attivita' antiossidante e loro impiego |
US8268806B2 (en) * | 2007-08-10 | 2012-09-18 | Endorecherche, Inc. | Pharmaceutical compositions |
EP2734193B1 (en) * | 2011-07-19 | 2015-05-20 | Pantarhei Bioscience B.V. | Tablet containing dehydroepiandrosterone (dhea) |
DE102012101680A1 (de) * | 2012-02-29 | 2013-08-29 | Aicuris Gmbh & Co. Kg | Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat |
EP2986634B1 (en) * | 2013-04-19 | 2019-11-20 | University of Houston System | Cocrystalline dhea formulations |
ES2914305T3 (es) | 2017-12-26 | 2022-06-09 | Ind Tech Res Inst | Composición para mejorar la solubilidad de sustancias poco solubles, uso de la misma y formulación compleja que contiene la misma |
EP3666260A1 (en) | 2018-12-13 | 2020-06-17 | Laboratorios Leon Farma SA | Ethinyl estradiol-beta-cyclodextrin complex and process for preparing thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2647343B1 (fr) * | 1989-05-24 | 1994-05-06 | Rhone Poulenc Sante | Nouvelle forme pharmaceutique poreuse et sa preparation |
US4978532A (en) * | 1989-08-11 | 1990-12-18 | Pharmedic Co. | Dosage form for administration of dehydroepiandrosterone |
US5120720A (en) * | 1990-09-20 | 1992-06-09 | The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services | Preparation of lipophile:hydroxypropylcyclodextrin complexes by a method using co-solubilizers |
WO1994004155A1 (en) * | 1992-08-19 | 1994-03-03 | Health Resource Institute, Ltd. | Dehydroepiandrosterone therapy for the treatment of eye disorders |
WO1995015746A1 (en) * | 1993-12-10 | 1995-06-15 | The School Of Pharmacy | Liposome delivery systems |
WO1997017992A1 (en) * | 1995-11-13 | 1997-05-22 | Supergen, Inc. | Improved formulation for administration of steroid compounds |
-
1998
- 1998-12-18 IT IT1998MI002745A patent/IT1304190B1/it active
-
1999
- 1999-12-14 CO CO99077980A patent/CO5231137A1/es not_active Application Discontinuation
- 1999-12-14 TW TW088121876A patent/TWI225791B/zh not_active IP Right Cessation
- 1999-12-14 AR ARP990106362A patent/AR021663A1/es not_active Application Discontinuation
- 1999-12-16 TR TR2001/01766T patent/TR200101766T2/xx unknown
- 1999-12-16 PE PE1999001262A patent/PE20001379A1/es not_active Application Discontinuation
- 1999-12-16 AU AU19810/00A patent/AU759979B2/en not_active Ceased
- 1999-12-16 IL IL14377699A patent/IL143776A0/xx not_active IP Right Cessation
- 1999-12-16 NZ NZ512795A patent/NZ512795A/en unknown
- 1999-12-16 HU HU0104822A patent/HU225414B1/hu not_active IP Right Cessation
- 1999-12-16 JP JP2000589219A patent/JP2002532565A/ja active Pending
- 1999-12-16 PT PT99963559T patent/PT1140110E/pt unknown
- 1999-12-16 AT AT99963559T patent/ATE243517T1/de not_active IP Right Cessation
- 1999-12-16 EP EP99963559A patent/EP1140110B1/en not_active Expired - Lifetime
- 1999-12-16 EA EA200100674A patent/EA003304B1/ru not_active IP Right Cessation
- 1999-12-16 ES ES99963559T patent/ES2203232T3/es not_active Expired - Lifetime
- 1999-12-16 CA CA002355148A patent/CA2355148A1/en not_active Abandoned
- 1999-12-16 WO PCT/EP1999/010010 patent/WO2000037109A2/en active IP Right Grant
- 1999-12-16 KR KR1020017007454A patent/KR100693514B1/ko not_active IP Right Cessation
- 1999-12-16 BR BR9916288-1A patent/BR9916288A/pt not_active IP Right Cessation
- 1999-12-16 DK DK99963559T patent/DK1140110T3/da active
- 1999-12-16 CN CNB998157716A patent/CN1198620C/zh not_active Expired - Fee Related
- 1999-12-16 DE DE69909128T patent/DE69909128T2/de not_active Expired - Fee Related
-
2001
- 2001-06-14 IL IL143776A patent/IL143776A/en unknown
- 2001-06-25 ZA ZA200105223A patent/ZA200105223B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ES2203232T3 (es) | 2004-04-01 |
JP2002532565A (ja) | 2002-10-02 |
CN1198620C (zh) | 2005-04-27 |
IL143776A0 (en) | 2002-04-21 |
PT1140110E (pt) | 2003-11-28 |
BR9916288A (pt) | 2001-10-16 |
DK1140110T3 (da) | 2003-10-20 |
IL143776A (en) | 2007-03-08 |
WO2000037109A3 (en) | 2000-09-14 |
PE20001379A1 (es) | 2000-11-25 |
NZ512795A (en) | 2003-08-29 |
ATE243517T1 (de) | 2003-07-15 |
CA2355148A1 (en) | 2000-06-29 |
DE69909128D1 (de) | 2003-07-31 |
WO2000037109A2 (en) | 2000-06-29 |
HUP0104822A2 (hu) | 2002-05-29 |
EA003304B1 (ru) | 2003-04-24 |
ZA200105223B (en) | 2002-09-25 |
CN1333686A (zh) | 2002-01-30 |
AU759979B2 (en) | 2003-05-01 |
AU1981000A (en) | 2000-07-12 |
EP1140110A2 (en) | 2001-10-10 |
HUP0104822A3 (en) | 2002-08-28 |
CO5231137A1 (es) | 2002-12-27 |
HU225414B1 (en) | 2006-11-28 |
DE69909128T2 (de) | 2004-05-06 |
KR100693514B1 (ko) | 2007-03-14 |
IT1304190B1 (it) | 2001-03-08 |
ITMI982745A1 (it) | 2000-06-18 |
EA200100674A1 (ru) | 2001-12-24 |
TWI225791B (en) | 2005-01-01 |
EP1140110B1 (en) | 2003-06-25 |
KR20010086109A (ko) | 2001-09-07 |
TR200101766T2 (tr) | 2001-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR021663A1 (es) | Clatratos de dehidroepiandrosterona y composiciones farmaceuticas correspondientes | |
AR032204A1 (es) | Complejos de inclusion de ciclodextrina-drospirenona | |
HU230005B1 (en) | Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid | |
CR10732A (es) | Uso de valerato de estradiol o 17 b- estradiol en combinacion con dienogest en una terapia oral para mantener y / o incrementar la libido femenina | |
UY28213A1 (es) | Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos. | |
GT200100152A (es) | Nueva composicion farmaceutica para el tratamiento de la obesidad. | |
GT200200114A (es) | Champues con alcohol de behenilo | |
BRPI0508359A (pt) | composições de pelìcula | |
ES2162319T3 (es) | Uso del agente quelante clioquinol para la fabricacion de una composicion farmaceutica para el tratamiento de la enfermedad de alzheimer. | |
AR054806A1 (es) | Formulaciones de estrogenos conjugados y bazedoxifeno | |
GT200800107A (es) | Formulaciones orales que comprenden tigeciclina | |
AR036640A1 (es) | Formulaciones y uso de las mismas | |
PE20080400A1 (es) | Composicion farmaceutica para la anticoncepcion y para reducir el riesgo de malformaciones congenitas | |
BR112022019223A2 (pt) | Formulação de complexo de inclusão em ciclodextrina (cd), complexo de inclusão em ciclodextrina (cd), uso da formulação de complexo de inclusão em ciclodextrina (cd), uso de um veículo de entrega de um complexo de inclusão em ciclodextrina, método para o tratamento oral de uma disfunção, método para o tratamento oral de um humano, uso da composição, composição e método de tratamento de um transtorno das vias aéreas | |
EP1469886B8 (en) | Lyophilized pharmaceutical composition of propofol | |
AR041826A1 (es) | Formulaciones de liberacion prolongada en formas de suspension | |
AR030140A1 (es) | Composiciones derivadas de la 2-piridinamina y metodos relacionados | |
BRPI0611526A2 (pt) | composição tópica contendo gelatina | |
UY26171A1 (es) | Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía | |
ES2188894T3 (es) | Lactonas macrociclicas perfumadas. | |
GT200400134A (es) | Sistemas emulsionantes que contienen derivados de azetidina | |
GT200400063A (es) | Composiciones solidas blandas con sineresis reducida | |
PE20050359A1 (es) | Composiciones topicas que comprenden terbinafina e hidrocortisona | |
AR036679A1 (es) | Formulaciones y uso de las mismas | |
GT200100218A (es) | Compuesto agroquimico. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |